Current diagnostic criteria for multiple sclerosis (MS) do not consider the optic nerve as a typical topography for establishing the diagnosis. Recent studies have proved the utility of optic nerve magnetic resonance imaging, optical coherence tomography and visual evoked potentials in detecting optic nerve lesions during the early stages of MS. In addition, emerging evidence supports the inclusion of optic nerve topography as a fifth region to fulfil the dissemination in space criteria. Anticipating a modification in the McDonald criteria, it is crucial for neurologists to familiarize with the diagnostic properties of each test in detecting optic nerve lesions and understand how to incorporate them into the MS diagnostic process. Therefore, the objective of this article is to review the existing evidence supporting the use of these tests in the diagnostic process of MS and provide a practical algorithm that can serve as a valuable guide for clinical practice.
McDonaldWICompstonAEdanG, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50(1): 121–127, http://onlinelibrary.wiley.com/doi/10.1002/ana.1032/full (accessed 5 April 2014).
4.
PolmanCHReingoldSCEdanG, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol2005; 58(6): 840–846, http://onlinelibrary.wiley.com/doi/10.1002/ana.20703/full (accessed 5 April 2014).
5.
PolmanCHReingoldSCBanwellB, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol2011; 69(2): 292–302, http://doi.wiley.com/10.1002/ana.22366 (accessed 5 April 2014).
6.
ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17(2): 162–173.
7.
van der Vuurst de VriesRMMescheriakovaJYWongYYM, et al. Application of the 2017 revised McDonald criteria for multiple sclerosis to patients with a typical clinically isolated syndrome. JAMA Neurol2018; 75(11): 1392, http://archneur.jamanetwork.com/article.aspx?doi=10.1001/jamaneurol.2018.2160 (accessed 12 February 2020).
8.
BrownleeWJSwantonJKAltmannDR, et al. Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria. J Neurol Neurosurg Psychiatr2015; 86(5): 584–585, http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2014-308675 (accessed 12 February 2020).
9.
ArrambideGTintoreMEspejoC, et al. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain2018; 141(4): 1075–1084.
HorwitzHFriisTModvigS, et al. Differential diagnoses to MS: Experiences from an optic neuritis clinic. J Neurol2014; 261(1): 98–105, http://link.springer.com/10.1007/s00415-013-7166-x (accessed 29 May 2023).
Vidal-JordanaARoviraAArrambideG, et al. Optic nerve topography in multiple sclerosis diagnosis: The utility of visual evoked potentials. Neurology2021; 96(4): e482–e490.
18.
BstehGHegenHAltmannP, et al. Diagnostic performance of adding the optic nerve region assessed by optical coherence tomography to the diagnostic criteria for MS. Neurology2023; 101: e784–e793, http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000207507 (accessed 4 July 2023).
19.
Vidal-JordanaARoviraACalderonW, et al. Adding the optic nerve in multiple sclerosis diagnostic criteria: A longitudinal, prospective, multicentre study. Neurology2024; 102: e200805.
WattjesMPCiccarelliOReichDS, et al2021MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol2021; 20(8): 653–670.
23.
HodelJOutteryckOBocherAL, et al. Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: Pilot study. Eur Radiol2014; 24(12): 3069–3075.
24.
RiedererIMühlauMHoshiMM, et al. Detecting optic nerve lesions in clinically isolated syndrome and multiple sclerosis: Double-inversion recovery magnetic resonance imaging in comparison with visually evoked potentials. J Neurol2019; 266(1): 148–156, http://link.springer.com/10.1007/s00415-018-9114-2 (accessed 12 June 2019).
25.
LondonFZéphirHDrumezE, et al. Optical coherence tomography: A window to the optic nerve in clinically isolated syndrome. Brain2019; 142(4): 903–915, https://academic.oup.com/brain/article/142/4/903/5371503 (accessed 12 June 2019).
26.
SartorettiTSartorettiERauchS, et al. How common is signal-intensity increase in optic nerve segments on 3D double inversion recovery sequences in visually asymptomatic patients with multiple sclerosis?Am J Neuroradiol2017; 38(9): 1748–1753, http://www.ajnr.org/lookup/doi/10.3174/ajnr.A5262 (accessed 3 July 2019).
27.
DavionJBLopesRDrumez LabreucheÉJ, et al. Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS. Neurology2020; 94: e2468–e2478.
28.
OutteryckOLopesRDrumez LabreucheÉJ, et al. Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome. Neurology2020; 95(6): e733–e744.
29.
BergSKaschkaIUtzKS, et al. Baseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritis (ed M Reindl). PLoS ONE2015; 10(1): e0113961, https://dx.plos.org/10.1371/journal.pone.0113961 (accessed 25 May 2022).
CellinaMFloridiCRostiC, et al. MRI of acute optic neuritis (ON) at the first episode: Can we predict the visual outcome and the development of multiple sclerosis (MS)?Radiol Med2019; 124(12): 1296–1303, http://link.springer.com/10.1007/s11547-019-01073-1 (accessed 25 May 2022).
32.
BursztynLLCDDe LottLBPetrouMCornblathWT. Sensitivity of orbital magnetic resonance imaging in acute demyelinating optic neuritis. Canad J Ophthalmol2019; 54(2): 242–246, https://linkinghub.elsevier.com/retrieve/pii/S0008418218303612 (accessed 25 May 2022).
33.
GabilondoIMartínez-LapiscinaEHFraga-PumarE, et al. Dynamics of retinal injury after acute optic neuritis. Ann Neurol2015; 77(3): 517–528.
34.
NolanRCGalettaSLFrohmanTC, et al. Optimal intereye difference thresholds in retinal nerve fiber layer thickness for predicting a unilateral optic nerve lesion in multiple sclerosis. J Neuro-Ophthalmol2018; 1, http://Insights.ovid.com/crossref?an=00041327-900000000-99287 (accessed 3 July 2019).
35.
Nolan-KenneyRCLiuMAkhandO, et al. Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study. Ann Neurol2019; 85(5): 618–629.
36.
BstehGHegenHAltmannP, et al. Validation of inter-eye difference thresholds in optical coherence tomography for identification of optic neuritis in multiple sclerosis. Mult Scler Relat Disord2020; 45: 102403, https://linkinghub.elsevier.com/retrieve/pii/S2211034820304788 (accessed 24 May 2022).
37.
PatilSAJosephBTaglianiP, et al. Longitudinal stability of inter-eye differences in optical coherence tomography measures for identifying unilateral optic nerve lesions in multiple sclerosis. J Neurol Sci2023; 449: 120669.
38.
CoricDBalkLJUitdehaagBMJ, et al. Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis. Eur J Neurol2017; 24(12): 1479–1484.
39.
PisaMCroeseTDalla CostaG, et al. Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes. Brain2021; 144(3): 848–862, https://academic.oup.com/brain/article/144/3/848/6215108 (accessed 5 March 2022).
40.
PatyDWOgerJJKastrukoffLF, et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology1988; 38(2): 180–185.
41.
FilippiniGComiGCCosiV, et al. Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis. J Neurol1994; 241(3): 132–137.
42.
GabelićTRadmilovićMPosavecV, et al. Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome. Acta Neurologica Belgica2013; 113(1): 13–17, http://link.springer.com/10.1007/s13760-012-0106-1 (accessed 22 July 2019).
43.
LeocaniLGuerrieriSComiG. Visual evoked potentials as a biomarker in multiple sclerosis and associated optic neuritis. J Neuro-Ophthalmol2018; 38(3): 350–357, http://Insights.ovid.com/crossref?an=00041327-201809000-00018 (accessed 26 June 2019).
44.
FrederiksenJLPetreraJ. Serial visual evoked potentials in 90 untreated patients with acute optic neuritis. Surv Ophthalmol1999; 44(Suppl. 1): S54–S62.
International Society for Clinical Electrophysiology of Vision, OdomJVBachM, et al. ISCEV standard for clinical visual evoked potentials: (2016 update). Docum Ophthalmol2016; 133(1): 1–9, http://link.springer.com/10.1007/s10633-016-9553-y (accessed 26 June 2019).
47.
TewariePBalkLCostelloF, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment (ed P Villoslada). PLoS ONE2012; 7(4): e34823, http://dx.plos.org/10.1371/journal.pone.0034823 (accessed 5 December 2016).
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
